Latest News, Events & Insights

The Center for Cancer and Blood Disorders proudly announces that Dr. Parra has been honored as one of the Top 150 Physicians in the Nation for Prostate Cancer!This recognition highlights his dedication, expertise, and the compassionate care he provides to every patient.View the Newsweek Rankings

The Center for Cancer and Blood Disorders is committed to continuously improving the patient experience through enhanced care services and facilities. 

Congratulations to Dr. Weng, the entire radiation oncology department, and our Las Colinas office for successfully treating their first thyroid cancer patient with I-131 radioactive iodine!Dr. Weng and the radiation oncology team built the program from the ground up. It allows us to provide an important treatment option for our patients after resection of their thyroid cancer.I-131 therapy is a form of nuclear medicine used to treat hyperthyroidism and certain types of thyroid cancer. When a radioactive iodine pill is swallowed, the I-131 is absorbed into the bloodstream and localized to the thyroid, any remaining normal thyroid tissue after surgery, or thyroid cancer. I-131 is able to ablate the thyroid in the setting of an overactive thyroid disease. Furthermore, where indicated, it has been shown to decrease the rate of thyroid cancer recurrence.Thank you to all of our Center family for your continued hard work and dedication to our patients!

Our medical oncology team in Ft Worth was the first in Tarrant County to treat a patient with BITE therapy for aggressive lymphoma—representing one of the newest treatment options for patients with advanced lymphoma.

Jodi McCartney discusses the importance of breast cancer awareness, early detection, and the resources available to support patients through their journey.

Dr. Gallaty discusses the different surgical options available for breast cancer patients, helping women understand their choices and make informed decisions about their treatment.

Several years ago HCA Weatherford established a new Internal Medicine Residency Program. Dr. Ray Page played an integral part in the development of the program and served on the founding Graduate Medical Education Committee, participating in didactic education, directing tumor boards, and supervising the clinical rotations in hematology and oncology. The residency has attracted a number of high-quality medical school graduates."Through the exposure of hematology and oncology practice from our Weatherford team of Dr. Riaz, Dr. Young, Dr. Skiba, Dr. Laine, and myself, we now have a number of bright residents that have developed a keen interest in pursuing an oncology fellowship and becoming cancer doctors", exclaims Dr. Page. "I always aspire to try to put them in a position for success and be able to achieve their dreams".Dr. Page has mentored some of these doctors. This last month, Dr. Joseph Kim and Dr. Minh-Treit Nguyen, two residents achieved peer-reviewed scientific publications with Dr. Page. He has them also working on a cancer registry study evaluating the impact of COVID lockdown policies on access to cancer screening worsening cancer stage and outcomes. Dr. Page sponsored Dr. Kim to present his paper at the upcoming Texas Society of Clinical Oncology meeting."Rarely do residents have the opportunity to present their work at this meeting and I am proud of Dr. Kim", states Dr. Page. He also endorsed Dr. Kim, where he received a scholarship to attend the Clinical Pathways Congress and Oncology Business Summit in Boston this Fall.Dr. Page is helping to establish a Senior Oncology Seminar Series at the residency program. He is also working to develop a new ASCO Oncology Interest Group at the MCW residency. All of these things will improve their exposure to get into oncology fellowship programs.Dr. Joseph Kim, senior resident at HCA Weatherford states, "I have my utmost appreciation for Dr. Page's invaluable assistance and guidance throughout this process. His support has been instrumental in shaping my professional journey, and I am truly grateful for his expertise and generosity. His unwavering commitment to mentoring and his profound knowledge in the field of oncology has been a source of my inspiration. I am honored to be a beneficiary of his mentorship".Dr. Page concludes, "It is exciting to see an exceptional young doctor, like Dr. Joseph Kim, aspiring to become our next generation of oncologists. It is always rewarding for me to be a mentor and share their successes".

Dr. Weng discusses the True Beam radiation therapy system available at our Arlington clinic, explaining how this advanced technology delivers precise, targeted treatment for cancer patients.

Dr. Ray Page, Director of Research, was in Chicago at the American Society of Clinical Oncology Annual Meeting with over 30,000 oncology professionals around the world presenting their scientific advances. Dr. Page was the co-author of two scientific studies presented at the meeting. First of its kind data was shared on using Artificial Intelligence-based radiographic imaging models to predict immunotherapy responses in advanced lung cancer patients.The Center was the first cancer center in the world to contribute radiomic data to create predictive algorithms. Dr. Page was strongly involved in consulting and providing clinical context to the design of the models."Russell Tarver, Director of Radiology Services played an integral role in curating vital radiomic data for the study. The Center once again takes the lead in research and innovation of cancer care delivery", states Dr. Page.Dr. Page also served on the Scientific Planning Committee for the Healthcare Delivery and Policy section of the ASCO meeting, coordinating and managing hundreds of presentations at the meeting. Dr. Page also attended the ASCO State Affiliate Council meeting, where for 12 years he has served as the Representative of the State of Texas, addressing critical and evolving policy and healthcare issues in oncology.

Medical City Plano is the first hospital in Texas to use a new robot with humanoid arms for minimally invasive gynecological surgeries.By Alice Laussade, D MagazineRead the Full Article